WuXi Biologics Achieves CDP Highest "A" Ratings in Both Climate Change and Water Security
COPTCOPT(US:CDP) Prnewswire·2025-12-19 09:30

Core Viewpoint - WuXi Biologics has been recognized with "A" ratings by CDP for both Climate Change and Water Security in 2025, highlighting its commitment to environmental stewardship and transparency [1] Climate Change Leadership - The "A" rating for Climate Change reflects WuXi Biologics' strong environmental performance and its validated integrated climate change strategy, aiming for net-zero emissions across its value chain by 2050 [2] - The company has implemented initiatives such as energy efficiency programs, process optimization, and renewable energy adoption, with its biologics facility in Ireland operating on 100% renewable electricity [2] Water Security Excellence - WuXi Biologics has achieved a place on the CDP Water Security "A" List for the third consecutive year, demonstrating its commitment to sustainable water management [3] - The company aims to reduce water consumption intensity by 30% by the end of 2025 compared to a 2019 baseline and has launched a Water Excellence Stewardship program covering various aspects of water management [3] Supplier Engagement - Earlier in the year, WuXi Biologics received an "A" rating in the CDP's Supplier Engagement assessment, recognizing its efforts to drive climate action across its value chain [4] - The company collaborates with global suppliers to promote a sustainable economy through a comprehensive supply chain management system and Scope 3 emissions tracking [4] Leadership Commentary - Dr. Chris Chen, CEO of WuXi Biologics, expressed pride in receiving the "A" ratings, reinforcing the company's commitment to sustainability and its role as a leader in green biologics [5] Industry Recognition - WuXi Biologics has received multiple accolades for its sustainability efforts, including an MSCI AAA Rating, EcoVadis Platinum Medal, and recognition in various sustainability indices [5] Company Overview - WuXi Biologics is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) providing end-to-end solutions for biologics [6] - The company employs over 12,000 skilled professionals across multiple countries and supports 864 integrated client projects, including 24 in commercial manufacturing as of June 30, 2025 [7] Commitment to Sustainability - The company views sustainability as essential for long-term growth and continuously innovates in green technology to provide advanced CRDMO solutions [8]